Simcere Pharmaceutical Co., Ltd
Clinical trials sponsored by Simcere Pharmaceutical Co., Ltd, explained in plain language.
-
New asthma drug aims to cut severe attacks in half
Disease control Recruiting nowThis study tests an experimental drug called SIM0718 for people with asthma that is not well controlled by current inhalers. About 418 adults and teens aged 12 to 75 will receive either the drug or a placebo for one year. The main goal is to see if the drug reduces the number of …
Phase: PHASE3 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could a simple tablet protect your brain after a stroke?
Disease control Recruiting nowThis study tests whether a sublingual tablet called edaravone dexborneol can help prevent or reduce thinking problems that often occur after a stroke. About 226 people who recently had a stroke and already show some cognitive issues will take the tablet or a placebo twice daily f…
Phase: PHASE2 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 26, 2026 12:37 UTC
-
New RSV drug for babies shows promise in phase 3 trial
Symptom relief Recruiting nowThis phase 3 trial tests an oral medicine called deurremidevir in infants and young children (1 month to 3 years old) with RSV infection. The goal is to see if it can shorten the time until symptoms like wheezing and rapid breathing go away. About 498 children will receive either…
Phase: PHASE3 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC